pyridoxal-isonicotinoyl-hydrazone and Fatty-Liver

pyridoxal-isonicotinoyl-hydrazone has been researched along with Fatty-Liver* in 1 studies

Other Studies

1 other study(ies) available for pyridoxal-isonicotinoyl-hydrazone and Fatty-Liver

Article	Year
Pyridoxal isonicotinoyl hydrazone inhibition of FXR is involved in the pathogenesis of isoniazid-induced liver injury. Toxicology and applied pharmacology, 2020, 09-01, Volume: 402 Topics: Animals; Apoptosis; Behavior, Animal; Bile Acids and Salts; Chemical and Drug Induced Liver Injury; Fatty Liver; Gene Expression Regulation; Hepatocytes; Humans; Isoniazid; Male; Models, Molecular; Necrosis; Protein Conformation; Pyridoxal; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; RNA, Messenger	2020

Article

Year

Pyridoxal isonicotinoyl hydrazone inhibition of FXR is involved in the pathogenesis of isoniazid-induced liver injury.

Toxicology and applied pharmacology, 2020, 09-01, Volume: 402

Topics: Animals; Apoptosis; Behavior, Animal; Bile Acids and Salts; Chemical and Drug Induced Liver Injury; Fatty Liver; Gene Expression Regulation; Hepatocytes; Humans; Isoniazid; Male; Models, Molecular; Necrosis; Protein Conformation; Pyridoxal; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; RNA, Messenger

2020